Saturday, July 11, 2026

Drug profile · INN

sitravatinib

sitravatinib is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — sitravatinib
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

sitravatinib is an FDA-listed pharmaceutical active ingredient.

Key facts

INN sitravatinib

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. GEM-2101 Phase 2 · Disc Medicine · Uveal melanoma
  2. Sitravatinib Phase 2 · BeiGene · Carcinoma, Hepatocellular

Frequently asked questions

What is sitravatinib?

sitravatinib is an FDA-listed pharmaceutical active ingredient.